Home ETF List About

ETF Holdings Breakdown of LH

Stock NameLaboratory Corporation of America Holdings
TickerLH(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS50540R4092
LEIOZ7UA8IXAIFILY2VZH07

LH institutional holdings

The following institutional investment holdings of LH have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-18 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 198,018 0.0%USD 54,880,689 0.4%
2025-09-18 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 198,018 0.0%USD 54,880,689 0.4%
2025-09-18 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 198,018 0.0%USD 54,880,689 0.4%
2025-09-18 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 139,007 0.1%USD 38,525,790 0.5%
2025-09-18 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 139,007 0.1%USD 38,525,790 0.5%
2025-09-18 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 139,007 0.1%USD 38,525,790 0.5%
2025-09-18 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 139,007 0.1%USD 38,525,790 0.5%
2025-09-18 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 8,865 0.3%USD 2,456,935 0.7%
2025-09-18 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 29,713 0.0%USD 8,234,958 0.4%
2025-09-18 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 27,728USD 7,684,815 0.4%
2025-09-18 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 27,728USD 7,684,815 0.4%
2025-09-18 IE00BYX2JD69 (iShares MSCI World SRI UCITS ETF) 46,930USD 13,006,650 0.4%
2025-09-18 IE00BMZ17T93 (iShares MSCI World SRI UCITS ETF GBP Hedged (Dist) GBP) 46,930USD 13,006,650 0.4%
2025-09-18 IE00BMZ17X30 (iShares MSCI World SRI UCITS ETF USD Hedged (Dist)) 46,930USD 13,006,650 0.4%
2025-09-18 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 23,580 0.3%USD 6,535,197 0.6%
2025-09-18 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 23,580 0.3%USD 6,535,197 0.6%
2025-09-18 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 23,580 0.3%USD 6,535,197 0.6%
2025-09-18 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 10,099USD 2,798,938 0.4%
2025-09-18 IE00BYVJRR92 (iShares MSCI USA SRI UCITS ETF USD (Acc)) 24,215 -0.1%USD 6,711,187 0.2%
2025-09-18 IE00BZ173V67 (iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)) 24,215 -0.1%USD 6,711,187 0.2%
2025-09-18 IE00BZ173T46 (iShares MSCI USA SRI UCITS ETF USD (Dist)) 24,215 -0.1%USD 6,711,187 0.2%
2025-09-18 IE00BMWPV470 (iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)) 24,215 -0.1%USD 6,711,187 0.2%
2025-09-18 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 13,245USD 3,117,231 1.0%
2025-09-18 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 14,538USD 4,029,207 0.4%
2025-09-18 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 14,538USD 4,029,207 0.4%
2025-09-18 IE00BP3QZB59 (iShares Edge MSCI World Value Factor UCITS ETF) 14,079USD 3,901,995 0.4%
2025-09-18 IE00BFYTYS33 (iShares Edge MSCI World Value Factor UCITS USD Dist) 14,079USD 3,901,995 0.4%
2025-09-18 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 6,376 -0.6%USD 1,767,108 -0.2%
2025-09-18 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 6,376 -0.6%USD 1,767,108 -0.2%
2025-09-18 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 33,502 0.1%USD 9,285,079 0.5%
2025-09-18 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 33,502 0.1%USD 9,285,079 0.5%
2025-09-18 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 5,353USD 1,259,837 1.0%
2025-09-18 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 39,489 0.1%USD 10,944,376 0.5%
2025-09-18 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 39,489 0.1%USD 10,944,376 0.5%
2025-09-18 IE00BD1F4M44 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP) 15,818USD 4,383,959 0.4%
2025-09-18 IE00BFF5RX68 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)) 15,818USD 4,383,959 0.4%
2025-09-18 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 3,465USD 960,325 0.4%
2025-09-18 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 1,869USD 517,993 0.4%
2025-09-18 IE00BKVL7778 (iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)) 2,510USD 695,647 0.4%
2025-09-18 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 1,396USD 386,901 0.4%
2025-09-18 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 1,396USD 386,901 0.4%
2025-09-18 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 1,978USD 404,488 1.2%
2025-09-18 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 501USD 138,852 0.4%
2025-09-18 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 501USD 138,852 0.4%
2025-09-18 IE000OKVTDF7 (iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)) 1,992USD 552,083 0.4%
2025-09-18 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 503USD 102,860 1.2%
2025-09-18 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 1,627USD 450,923 0.4%
2025-09-18 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 3,973USD 1,101,117 0.4%
2025-09-18 IE00013A2XD6 (iShares MSCI ACWI SRI UCITS ETF USD(Dist)) 479USD 132,755 0.4%
Total =1,850,997 USD 512,046,190
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with LH

Labcorp Announces Availability Of Lumipulse PTau-217/Beta Amyloid 42 Ratio For Alzheimer's Diagnosis
(RTTNews) - Labcorp Holdings Inc. (LH), Monday announced the availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio, a blood-based in-vitro diagnostic test to aid in the diagnosis of Alzheimer's disease. - 2025-08-18 08:35:08
Truist Financial Issues Positive Forecast for Labcorp (NYSE:LH) Stock Price
Labcorp (NYSE:LH – Free Report) had its target price boosted by Truist Financial from $290.00 to $310.00 in a research report released on Friday morning,Benzinga reports. Truist Financial currently has a buy rating on the medical research company’s stock. Several other equities analysts also recently issued reports on LH. Morgan Stanley upped their price objective […] - 2025-07-28 04:00:48
Labcorp (NYSE:LH) Given New $305.00 Price Target at UBS Group
Labcorp (NYSE:LH – Free Report) had its price objective increased by UBS Group from $282.00 to $305.00 in a research note published on Friday,Benzinga reports. UBS Group currently has a buy rating on the medical research company’s stock. Several other brokerages have also recently weighed in on LH. Robert W. Baird boosted their price objective […] - 2025-07-28 04:00:47
Labcorp (NYSE:LH) Price Target Raised to $302.00
Labcorp (NYSE:LH – Free Report) had its price objective hoisted by Robert W. Baird from $290.00 to $302.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has an outperform rating on the medical research company’s stock. Several other equities research analysts have also weighed in on the stock. UBS Group […] - 2025-07-28 03:14:44
Labcorp (NYSE:LH) Raised to Buy at Wall Street Zen
Labcorp (NYSE:LH – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. Other analysts also recently issued research reports about the stock. HSBC downgraded shares of Labcorp from a “buy” rating to a “hold” rating and set a […] - 2025-07-28 03:14:44
Labcorp (NYSE:LH) Price Target Raised to $306.00
Labcorp (NYSE:LH – Free Report) had its price target increased by Morgan Stanley from $283.00 to $306.00 in a research report report published on Friday morning,Benzinga reports. Morgan Stanley currently has an overweight rating on the medical research company’s stock. LH has been the subject of several other reports. Truist Financial raised their price objective […] - 2025-07-28 03:14:44
Labcorp Boosts FY25 Outlook - Update
(RTTNews) - While reporting financial results for the second quarter on Thursday, life sciences company Labcorp (LH) raised its adjusted earnings and revenue guidance for the full-year 2025 to reflect its second quarter performance and full year outlook. - 2025-07-24 08:41:35
Larson Financial Group LLC Increases Stock Position in Labcorp Holdings Inc. (NYSE:LH)
Larson Financial Group LLC boosted its stake in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 140.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 125 shares of the medical research company’s stock after purchasing an additional 73 shares during […] - 2025-07-23 05:53:06
Signaturefd LLC Increases Stock Holdings in Labcorp Holdings Inc. (NYSE:LH)
Signaturefd LLC boosted its position in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 9.7% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 645 shares of the medical research company’s stock after purchasing an additional 57 shares during the period. Signaturefd LLC’s holdings in Labcorp […] - 2025-07-21 05:43:02
UBS Group Cuts Labcorp (NYSE:LH) Price Target to $282.00
Labcorp (NYSE:LH – Free Report) had its price target decreased by UBS Group from $284.00 to $282.00 in a report released on Friday,Benzinga reports. UBS Group currently has a buy rating on the medical research company’s stock. Several other analysts have also recently commented on LH. Hsbc Global Res cut shares of Labcorp from a […] - 2025-07-21 04:54:54
Labcorp Holdings Inc. (NYSE:LH) Receives $276.08 Average PT from Brokerages
Shares of Labcorp Holdings Inc. (NYSE:LH – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating, nine have issued a buy rating and […] - 2025-07-11 04:01:04
Labcorp Holdings Inc. (NYSE:LH) Shares Acquired by D.A. Davidson & CO.
D.A. Davidson & CO. lifted its holdings in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 1.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 11,851 shares of the medical research company’s stock after buying an additional 204 shares during the quarter. D.A. Davidson & CO.’s holdings in Labcorp were […] - 2025-07-07 07:13:02
DAVENPORT & Co LLC Sells 269 Shares of Labcorp Holdings Inc. (NYSE:LH)
DAVENPORT & Co LLC trimmed its position in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 6.7% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 3,720 shares of the medical research company’s stock after selling 269 shares during the quarter. DAVENPORT & Co LLC’s holdings in Labcorp were worth $866,000 as of its […] - 2025-07-07 05:54:49
Vontobel Holding Ltd. Trims Stock Position in Labcorp Holdings Inc. (NYSE:LH)
Vontobel Holding Ltd. lessened its stake in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 43.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,832 shares of the medical research company’s stock after selling 2,177 shares during the quarter. Vontobel Holding […] - 2025-07-07 05:03:35
Amalgamated Bank Grows Position in Labcorp Holdings Inc. (NYSE:LH)
Amalgamated Bank increased its position in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 1.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,303 shares of the medical research company’s stock after buying an additional 248 shares during the period. Amalgamated Bank’s holdings […] - 2025-07-04 05:24:51
Labcorp Holdings Inc. (NYSE:LH) Stock Holdings Lifted by Cambridge Investment Research Advisors Inc.
Cambridge Investment Research Advisors Inc. increased its position in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 0.9% during the first quarter, Holdings Channel reports. The fund owned 10,075 shares of the medical research company’s stock after acquiring an additional 92 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Labcorp […] - 2025-07-02 04:38:52
Chevy Chase Trust Holdings LLC Sells 308 Shares of Labcorp Holdings Inc. (NYSE:LH)
Chevy Chase Trust Holdings LLC lowered its position in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 0.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 47,565 shares of the medical research company’s stock after selling 308 shares during the […] - 2025-06-27 05:12:50
Envestnet Portfolio Solutions Inc. Sells 3,171 Shares of Labcorp Holdings Inc. (NYSE:LH)
Envestnet Portfolio Solutions Inc. cut its holdings in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 31.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,898 shares of the medical research company’s stock after selling 3,171 shares during the period. Envestnet […] - 2025-06-24 05:18:50
Exchange Traded Concepts LLC Trims Position in Labcorp Holdings Inc. (NYSE:LH)
Exchange Traded Concepts LLC reduced its holdings in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 5.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 890 shares of the medical research company’s stock after selling 55 shares during the period. Exchange Traded Concepts […] - 2025-06-24 05:18:50
Wealth Enhancement Advisory Services LLC Boosts Stock Holdings in Labcorp Holdings Inc. (NYSE:LH)
Wealth Enhancement Advisory Services LLC grew its holdings in Labcorp Holdings Inc. (NYSE:LH – Free Report) by 84.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 36,182 shares of the medical research company’s stock after purchasing an additional 16,574 shares during […] - 2025-06-24 04:32:49
Garde Capital Inc. Takes $36,000 Position in Labcorp Holdings Inc. (NYSE:LH)
Garde Capital Inc. acquired a new stake in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 154 shares of the medical research company’s stock, valued at approximately $36,000. Other institutional investors […] - 2025-06-23 06:02:47
Assenagon Asset Management S.A. Has $898,000 Holdings in Labcorp Holdings Inc. (NYSE:LH)
Assenagon Asset Management S.A. decreased its stake in shares of Labcorp Holdings Inc. (NYSE:LH – Free Report) by 2.2% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,858 shares of the medical research company’s stock after selling 85 shares during the […] - 2025-06-19 04:50:52
CX Institutional Lowers Position in Laboratory Co. of America Holdings (NYSE:LH)
CX Institutional cut its stake in Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 6.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 878 shares of the medical research company’s stock after selling 57 shares during the quarter. CX […] - 2025-06-15 05:58:50
UMB Bank n.a. Purchases 77 Shares of Laboratory Co. of America Holdings (NYSE:LH)
UMB Bank n.a. lifted its position in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 19.8% during the 1st quarter, HoldingsChannel reports. The firm owned 465 shares of the medical research company’s stock after acquiring an additional 77 shares during the period. UMB Bank n.a.’s holdings in Laboratory Co. of America […] - 2025-06-13 04:50:55
Procyon Advisors LLC Purchases Shares of 876 Laboratory Co. of America Holdings (NYSE:LH)
Procyon Advisors LLC acquired a new stake in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 876 shares of the medical research company’s stock, valued at approximately $204,000. Other institutional investors and […] - 2025-06-10 05:32:59
Laboratory Co. of America Holdings (NYSE:LH) Shares Purchased by Merit Financial Group LLC
Merit Financial Group LLC grew its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 23.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,414 shares of the medical research company’s stock after acquiring an additional 639 […] - 2025-06-09 05:14:56
Squarepoint Ops LLC Has $694,000 Stake in Laboratory Co. of America Holdings (NYSE:LH)
Squarepoint Ops LLC decreased its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 85.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,025 shares of the medical research company’s stock after selling 18,221 shares […] - 2025-06-03 05:05:01
Labcorp Announces New Test Offerings For Solid Tumor And Hematologic Malignancies
(RTTNews) - Labcorp (LH) announced the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and hematologic malignancies and enhanced biopharma solutions. - 2025-05-30 08:34:57
Laboratory Co. of America Holdings (NYSE:LH) Shares Sold by State of Wyoming
State of Wyoming reduced its stake in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 82.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 363 shares of the medical research company’s stock after selling 1,677 shares during the […] - 2025-05-28 05:46:58
Laboratory Co. of America Holdings (NYSE:LH) Stake Lessened by Man Group plc
Man Group plc decreased its holdings in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 87.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,016 shares of the medical research company’s stock after selling 7,046 shares during […] - 2025-05-28 05:00:50

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.